Darifenacin provides meaningful improvements to patients dissatisfied with oxybutynin or tolterodine therapy

Abstract Category

Neurourology: Clinical

Links
	Abstract 454
	Non-Discussion Posters Scientific Non Discussion Poster Session 32
	1. University of Pennsylvania, 2. Procter & Gamble Pharmaceuticals
Abstract PDF Edit Abstract Abstract Centre